These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5919749)

  • 1. Histamine synthesis in man: inhibition by 4-bromo-3-hydroxybenzyloxyamine.
    Levine RJ
    Science; 1966 Nov; 154(3752):1017-9. PubMed ID: 5919749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of urinary histamine excretion and 24h urine volumes in rats and man.
    Horlington M; Kolthammer JC; Lazare R
    J Pharm Pharmacol; 1970 Oct; 22(10):793-5. PubMed ID: 4394795
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral disodium cromoglycate in mastocytosis.
    Zachariae H; Herlin T; Larsen PO
    Acta Derm Venereol; 1981; 61(3):272-3. PubMed ID: 6167118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood and urine histamine levels in normal and pathological states as measured by a radiochemical assay.
    Horakova Z; Keiser HR; Beaven MA
    Clin Chim Acta; 1977 Sep; 79(2):447-56. PubMed ID: 890980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites.
    Keyzer JJ; de Monchy JG; van Doormaal JJ; van Voorst Vader PC
    N Engl J Med; 1983 Dec; 309(26):1603-5. PubMed ID: 6646186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of histamine, methylhistamine (1-MeHi) and methylimidazoleacetic acid (MeImAA) in mastocytosis: comparison of new HPLC methods with other present methods.
    Granerus G; Wass U
    Agents Actions; 1984 Apr; 14(3-4):341-5. PubMed ID: 6731175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of isoprenaline and terbutaline on urinary excretion of histamine and its two main metabolites in systemic mastocytosis.
    van Doormaal JJ; Idema IG; de Monchy JG; Breukelman H; Keyzer JJ; Doorenbos H
    Agents Actions; 1986 Apr; 18(1-2):269-72. PubMed ID: 3728212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine excretion and dermographism in urticaria pigmentosa before and after administration of a specific histidine-decarboxylase inhibitor.
    Greaves MW
    Br J Dermatol; 1971 Nov; 85(5):467-70. PubMed ID: 4108905
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of skeletal scintigraphy and their relationship to plasma and urinary histamine levels in systemic mastocytosis.
    Rosenbaum RC; Frieri M; Metcalfe DD
    J Nucl Med; 1984 Aug; 25(8):859-64. PubMed ID: 6235329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mastocytosis without urticaria pigmentosa: a frequently unrecognized cause of recurrent syncope.
    Roberts LJ; Fields JP; Oates JA
    Trans Assoc Am Physicians; 1982; 95():36-41. PubMed ID: 7182985
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased urinary methylimidazoleacetic acid (MelmAA) as an indicator of systemic mastocytosis.
    Granerus G; Roupe G
    Agents Actions; 1982 Apr; 12(1-2):29-31. PubMed ID: 7080964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basophil/mast cell precursors in mast cell proliferative disorders.
    Denburg JA; Telizyn S; Ahlstedt S; Olafsson JH; Roupe G; Bienenstock J
    Clin Invest Med; 1986; 9(1):21-5. PubMed ID: 3955917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histaminuria in urticaria pigmentosa. A clinical study and review of recent literature with definition of the mastocytosis syndrome.
    DEMIS DJ; WALTON MD; HIGDON RS
    Arch Dermatol; 1961 Jan; 83():127-38. PubMed ID: 13721777
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of the radioenzymatic method for the determination of urinary histamine with a mass spectrometric assay.
    Roberts LJ; Aulsebrook KA; Oates JA
    J Chromatogr; 1985 Feb; 338(1):41-9. PubMed ID: 4019656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on urticaria pigmentosa.
    Roychowdhury DS; Banerjee AK
    Bull Calcutta Sch Trop Med; 1971 Apr; 19(2):39-40. PubMed ID: 4144296
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic mastocytosis with myeloid splenomegaly type hematological manifestations].
    Krulik M; Brivet F; Audebert AA; Curioni S; Debray J
    Ann Med Interne (Paris); 1977 Mar; 128(3):245-53. PubMed ID: 869393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urticaria pigmentosa. Histaminuria and treatment.
    Tabar AI; Vives R; Valcayo A; Montes M; Varela JI
    Allergol Immunopathol (Madr); 1990; 18(2):101-3. PubMed ID: 1973586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.
    Olafsson JH
    Acta Derm Venereol Suppl (Stockh); 1985; 115():1-43. PubMed ID: 3901645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies of histidine and histamine metabolism in urticaria pigmentosa.
    DEMIS DJ; WALTON MD; WOOLEY D; WILNER N; McNEIL G
    J Invest Dermatol; 1961 Dec; 37():513-21. PubMed ID: 13885343
    [No Abstract]   [Full Text] [Related]  

  • 20. Histaminuria after parenteral L-histidine administration in man.
    Döhlen H; Nornes H; Sjaastad O; Sjaastad OV
    Acta Physiol Scand; 1973 Sep; 89(1):51-60. PubMed ID: 4761520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.